|
Nyandiko W, Holland S, Vreeman R, DeLong AK, Manne A, Novitsky V, Sang F, Ashimosi C, Ngeresa A, Chory A, Aluoch J, Orido M, Jepkemboi E, Sam SS, Caliendo AM, Ayaya S, Hogan JW, Kantor R, Resistance in a Pediatric Cohort (RESPECT) Study.
"HIV-1 Treatment Failure, Drug Resistance, and Clinical Outcomes in Perinatally Infected Children and Adolescents Failing First-Line Antiretroviral Therapy in Western Kenya." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 89, no. 2, 2022, pp. 231-239.
|
|
Guang, August, Howison, Mark, Ledingham, Lauren, D’Antuono, Matthew, Chan, Philip A., Lawrence, Charles, Dunn, Casey W., Kantor, Rami.
"Incorporating Within-Host Diversity in Phylogenetic Analyses for Detecting Clusters of New HIV Diagnoses." Frontiers in Microbiology, vol. 12, 2022.
|
|
Vreeman, Rachel C, Rakhmanina, Natella Y, Nyandiko, Winstone M, Puthanakit, Thanyawee, Kantor, Rami.
"Are we there yet? 40 years of successes and challenges for children and adolescents living with HIV." Journal of the International AIDS Society, vol. 24, no. 6, 2021, pp. e25759.
|
|
Beckwith CG, Min S, Manne A, Novitsky V, Howison M, Liu T, Kuo I, Kurth A, Bazerman L, Agopian A, Kantor R.
"HIV Drug Resistance and Transmission Networks Among a Justice-Involved Population at the Time of Community Reentry in Washington, D.C." AIDS Research and Human Retroviruses, vol. 37, no. 12, 2021, pp. 903-912.
|
|
Novitsky V, Steingrimsson J, Howison M, Dunn C, Gillani FS, Manne A, Li Y, Spence M, Parillo Z, Fulton J, Marak T, Chan P, Bertrand T, Bandy U, Alexander-Scott N, Hogan J, Kantor R.
"Longitudinal typing of molecular HIV clusters in a statewide epidemic." AIDS, vol. 35, no. 11, 2021, pp. 1711-1722.
|
|
Kantor, Rami.
"Next Generation Sequencing for HIV-1 Drug Resistance Testing—A Special Issue Walkthrough." Viruses, vol. 13, no. 2, 2021, pp. 340.
|
|
Kofman, Aaron, Kantor, Rami, Adashi, Eli Y.
"Potential COVID-19 Endgame Scenarios." JAMA, vol. 326, no. 4, 2021, pp. 303-304.
|
|
Aung S, Hardy N, Chrysanthopoulou SA, Kyaw A, San Tun M, Aung KW, Rana A, Kantor R.
"Stigma Determines Antiretroviral Adherence in Adults With HIV in Myanmar." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 89, no. 1, 2021, pp. 19-26.
|
|
Noska, Amanda, Liu, Tao, Kuo, Irene, Bazerman, Lauri, Kurth, Ann, Coetzer, Mia, Kantor, Rami, Beckwith, Curt.
"Validity of Self-Reported Hepatitis C Virus Status Among Criminal Justice-Involved Persons Living With HIV." Journal of Correctional Health Care, vol. 27, no. 3, 2021, pp. 167-171.
|
|
Tzou PL, Kosakovsky Pond SL, Avila-Rios S, Holmes SP, Kantor R, Shafer RW.
"Analysis of unusual and signature APOBEC-mutations in HIV-1 pol next-generation sequences." PLoS ONE, vol. 15, no. 2, 2020, pp. e0225352.
|
|
Kantor R, Fulton JP, Steingrimsson J, Novitsky V, Howison M, Gillani F, Li Y, Manne A, Parillo Z, Spence M, Marak T, Chan P, Dunn CW, Bertrand T, Bandy U, Alexander-Scott N, Hogan JW.
"Challenges in evaluating the use of viral sequence data to identify HIV transmission networks for public health." Statistical communications in infectious diseases, vol. 12, no. Suppl 1, 2020.
|
|
Novitsky V, Steingrimsson JA, Howison M, Gillani FS, Li Y, Manne A, Fulton J, Spence M, Parillo Z, Marak T, Chan PA, Bertrand T, Bandy U, Alexander-Scott N, Dunn CW, Hogan J, Kantor R.
"Empirical comparison of analytical approaches for identifying molecular HIV-1 clusters." Scientific reports, vol. 10, no. 1, 2020, pp. 18547.
|
|
Ji H, Parkin N, Gao F, Denny T, Jennings C, Sandstrom P, Kantor R.
"External Quality Assessment Program for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Logistical Considerations." Viruses, vol. 12, no. 5, 2020.
|
|
Parkin NT, Avila-Rios S, Bibby DF, Brumme CJ, Eshleman SH, Harrigan PR, Howison M, Hunt G, Ji H, Kantor R, Ledwaba J, Lee ER, Matías-Florentino M, Mbisa JL, Noguera-Julian M, Paredes R, Rivera-Amill V, Swanstrom R, Zaccaro DJ, Zhang Y, Zhou S, Jennings C.
"Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance Genotyping." Viruses, vol. 12, no. 7, 2020.
|
|
Lee ER, Parkin N, Jennings C, Brumme CJ, Enns E, Casadellà M, Howison M, Coetzer M, Avila-Rios S, Capina R, Marinier E, Van Domselaar G, Noguera-Julian M, Kirkby D, Knaggs J, Harrigan R, Quiñones-Mateu M, Paredes R, Kantor R, Sandstrom P, Ji H.
"Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing." Scientific reports, vol. 10, no. 1, 2020, pp. 1634.
|
|
Byrd KM, Beckwith CG, Garland JM, Johnson JE, Aung S, Cu-Uvin S, Farmakiotis D, Flanigan T, Gillani FS, Macias-Gil R, Mileno M, Ramratnam B, Rybak NR, Sanchez M, Tashima K, Mylonakis E, Kantor R.
"SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States." Journal of the International AIDS Society, vol. 23, no. 7, 2020, pp. e25573.
|
|
Xu Y, Liu T, Daniels MJ, Kantor R, Mwangi A, Hogan JW.
"Classification using ensemble learning under weighted misclassification loss." Statistics in Medicine, vol. 38, no. 11, 2019, pp. 2002-2012.
|
|
Reece, Rebecca, Delong, Allison, Matthew, D’Antuono, Tashima, Karen, Kantor, Rami.
"Accumulated pre-switch resistance to more recently introduced one-pill-once-a-day antiretroviral regimens impacts HIV-1 virologic outcome." Journal of Clinical Virology, vol. 105, 2018, pp. 11-17.
|
|
Saravanan S, Gomathi S, Delong A, Kausalya B, Sivamalar S, Poongulali S, Brooks K, Kumarasamy N, Balakrishnan P, Solomon SS, Cu-Uvin S, Kantor R.
"High discordance in blood and genital tract HIV-1 drug resistance in Indian women failing first-line therapy." Journal of Antimicrobial Chemotherapy, vol. 73, no. 8, 2018, pp. 2152-2161.
|
|
Kantor R, DeLong A, Schreier L, Reitsma M, Kemboi E, Orido M, Obonge S, Boinett R, Rono M, Emonyi W, Brooks K, Coetzer M, Buziba N, Hogan J, Diero L.
"HIV-1 second-line failure and drug resistance at high-level and low-level viremia in Western Kenya." AIDS, vol. 32, no. 17, 2018, pp. 2485-2496.
|
|
Chan, Philip A., Montgomery, Madeline C., Rose, Jennifer, Tributino, Alec, Crowley, Christina, Medina, Martha M., Patel, Rupa, Mayer, Kenneth, Kantor, Rami, Nunn, Amy S.
"Statewide Evaluation of New HIV Diagnoses in Rhode Island: Implications for Prevention." Public Health Reports, 2018, pp. 003335491877725.
|
|
Paredes R, Tzou PL, van Zyl G, Barrow G, Camacho R, Carmona S, Grant PM, Gupta RK, Hamers RL, Harrigan PR, Jordan MR, Kantor R, Katzenstein DA, Kuritzkes DR, Maldarelli F, Otelea D, Wallis CL, Schapiro JM, Shafer RW.
"Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretation." PLoS ONE, vol. 12, no. 7, 2017, pp. e0181357.
|
|
Duarte HA, Panpradist N, Beck IA, Lutz B, Lai J, Kanthula RM, Kantor R, Tripathi A, Saravanan S, MacLeod IJ, Chung MH, Zhang G, Yang C, Frenkel LM.
"Current Status of Point-of-Care Testing for Human Immunodeficiency Virus Drug Resistance." The Journal of Infectious Diseases, vol. 216, no. suppl_9, 2017, pp. S824-S828.
|
|
Saravanan S, Kausalya B, Gomathi S, Sivamalar S, Pachamuthu B, Selvamuthu P, Pradeep A, Sunil S, Mothi SN, Smith DM, Kantor R.
"Etravirine and Rilpivirine Drug Resistance Among HIV-1 Subtype C Infected Children Failing Non-Nucleoside Reverse Transcriptase Inhibitor-Based Regimens in South India." AIDS Research and Human Retroviruses, vol. 33, no. 6, 2017, pp. 567-574.
|
|
Coetzer M, Ledingham L, Diero L, Kemboi E, Orido M, Kantor R.
"Gp41 and Gag amino acids linked to HIV-1 protease inhibitor-based second-line failure in HIV-1 subtype A from Western Kenya." Journal of the International AIDS Society, vol. 20, no. 3, 2017.
|
|
Liu T, Hogan JW, Daniels MJ, Coetzer M, Xu Y, Bove G, DeLong AK, Ledingham L, Orido M, Diero L, Kantor R.
"Improved HIV-1 Viral Load Monitoring Capacity Using Pooled Testing With Marker-Assisted Deconvolution." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 75, no. 5, 2017, pp. 580-587.
|
|
Rhee SY, Varghese V, Holmes SP, Van Zyl GU, Steegen K, Boyd MA, Cooper DA, Nsanzimana S, Saravanan S, Charpentier C, de Oliveira T, Etiebet MA, Garcia F, Goedhals D, Gomes P, Günthard HF, Hamers RL, Hoffmann CJ, Hunt G, Jiamsakul A, Kaleebu P, Kanki P, Kantor R, Kerschberger B, Marconi VC, D'amour Ndahimana J, Ndembi N, Ngo-Giang-Huong N, Rokx C, Santoro MM, Schapiro JM, Schmidt D, Seu L, Sigaloff KCE, Sirivichayakul S, Skhosana L, Sunpath H, Tang M, Yang C, Carmona S, Gupta RK, Shafer RW.
"Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration." EBioMedicine, vol. 18, 2017, pp. 225-235.
|
|
Gregson J, Kaleebu P, Marconi VC, van Vuuren C, Ndembi N, Hamers RL, Kanki P, Hoffmann CJ, Lockman S, Pillay D, de Oliveira T, Clumeck N, Hunt G, Kerschberger B, Shafer RW, Yang C, Raizes E, Kantor R, Gupta RK.
"Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study." The Lancet Infectious Diseases, vol. 17, no. 3, 2017, pp. 296-304.
|
|
Godfrey C, Bobkova M, Boucher C, Ravasi G, Chen P, Zhang F, Wu Y, Kantor R.
"Regional Challenges in the Prevention of Human Immunodeficiency Virus Drug Resistance." The Journal of Infectious Diseases, vol. 216, no. suppl_9, 2017, pp. S816-S819.
|
|
Brooks K, DeLong A, Balamane M, Schreier L, Orido M, Chepkenja M, Kemboi E, D'Antuono M, Chan PA, Emonyi W, Diero L, Coetzer M, Kantor R.
"HemaSpot, a Novel Blood Storage Device for HIV-1 Drug Resistance Testing." Journal of clinical microbiology, vol. 54, no. 1, 2016, pp. 223-5.
|
|
Dufort, Elizabeth M., DeLong, Allison K., Mann, Marita, Nyandiko, Winstone M., Ayaya, Samuel O., Hogan, Joseph W., Kantor, Rami.
"Misclassification of Antiretroviral Treatment Failure Using WHO 2006 and 2010/2013 Immunologic Criteria in HIV-Infected Children and Adolescents in Western Kenya." Journal of the Pediatric Infectious Diseases Society, 2016, pp. piw018.
|
|
Chan PA, Towey C, Poceta J, Rose J, Bertrand T, Kantor R, Harvey J, Santamaria EK, Alexander-Scott N, Nunn A.
"Online Hookup Sites for Meeting Sexual Partners among Men Who Have Sex with Men in Rhode Island, 2013: A Call for Public Health Action." Public Health Reports, vol. 131, no. 2, 2016, pp. 264-271.
|
|
Brooks K, Diero L, DeLong A, Balamane M, Reitsma M, Kemboi E, Orido M, Emonyi W, Coetzer M, Hogan J, Kantor R.
"Treatment failure and drug resistance in HIV-positive patients on tenofovir-based first-line antiretroviral therapy in western Kenya." Journal of the International AIDS Society, vol. 19, no. 1, 2016, pp. 20798.
|
|
Rogo, T., DeLong, A. K., Chan, P., Kantor, R.
"Antiretroviral treatment failure, drug resistance, and subtype diversity in the only pediatric HIV clinic in Rhode Island." Clinical Infectious Diseases, vol. 60, no. 9, 2015, pp. 1426-35.
|
|
Huang A, Hogan JW, Luo X, DeLong A, Saravanan S, Wu Y, Sirivichayakul S, Kumarasamy N, Zhang F, Phanuphak P, Diero L, Buziba N, Istrail S, Katzenstein DA, Kantor R.
"Global Comparison of Drug Resistance Mutations After First-Line Antiretroviral Therapy Across Human Immunodeficiency Virus-1 Subtypes." Open Forum Infectious Diseases, vol. 3, no. 2, 2015, pp. ofv158.
|
|
Rhee SY, Jordan MR, Raizes E, Chua A, Parkin N, Kantor R, Van Zyl GU, Mukui I, Hosseinipour MC, Frenkel LM, Ndembi N, Hamers RL, Rinke de Wit TF, Wallis CL, Gupta RK, Fokam J, Zeh C, Schapiro JM, Carmona S, Katzenstein D, Tang M, Aghokeng AF, De Oliveira T, Wensing AM, Gallant JE, Wainberg MA, Richman DD, Fitzgibbon JE, Schito M, Bertagnolio S, Yang C, Shafer RW.
"HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing." PLoS ONE, vol. 10, no. 12, 2015, pp. e0145772.
|
|
Zhang, Lei, Wang, Jingjing, Coetzer, Mia, Angione, Stephanie, Kantor, Rami, Tripathi, Anubhav.
"One-Step Ligation on RNA Amplification for the Detection of Point Mutations." The Journal of molecular diagnostics : JMD, vol. 17, no. 6, 2015, pp. 679-688.
|
|
Chan, Philip A., Hogan, Joseph W., Huang, Austin, DeLong, Allison, Salemi, Marco, Mayer, Kenneth H., Kantor, Rami.
"Phylogenetic Investigation of a Statewide HIV-1 Epidemic Reveals Ongoing and Active Transmission Networks Among Men Who Have Sex With Men." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 70, no. 4, 2015, pp. 428-35.
|
|
Kantor R, Smeaton L, Vardhanabhuti S, Hudelson SE, Wallis CL, Tripathy S, Morgado MG, Saravanan S, Balakrishnan P, Reitsma M, Hart S, Mellors JW, Halvas E, Grinsztejn B, Hosseinipour MC, Kumwenda J, La Rosa A, Lalloo UG, Lama JR, Rassool M, Santos BR, Supparatpinyo K, Hakim J, Flanigan T, Kumarasamy N, Campbell TB, Eshleman SH, AIDS Clinical Trials Group (ACTG) A5175 Study Team.
"Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial." Clinical Infectious Diseases, vol. 60, no. 10, 2015, pp. 1541-9.
|
|
Kantor R, Smeaton L, Vardhanabhuti S, Hudelson SE, Wallis CL, Tripathy S, Morgado MG, Saravanan S, Balakrishnan P, Reitsma M, Hart S, Mellors JW, Halvas E, Grinsztejn B, Hosseinipour MC, Kumwenda J, La Rosa A, Lalloo UG, Lama JR, Rassool M, Santos BR, Supparatpinyo K, Hakim J, Flanigan T, Kumarasamy N, Campbell TB, Eshleman SH, AIDS Clinical Trials Group (ACTG) A5175 Study Team.
"Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial." Clinical Infectious Diseases, vol. 60, no. 10, 2015, pp. 1541-9.
|
|
Oyomopito RA, Chen YJ, Sungkanuparph S, Kantor R, Merati T, Yam WC, Sirisanthana T, Li PC, Kantipong P, Phanuphak P, Lee CK, Kamarulzaman A, Ditangco R, Huang SW, Sohn AH, Law M, Chen YM.
"Risk group characteristics and viral transmission clusters in South-East Asian patients infected with human immunodeficiency virus-1 (HIV-1) circulating recombinant form (CRF) 01_AE and subtype B." The Kaohsiung journal of medical sciences, vol. 31, no. 9, 2015, pp. 445-53.
|
|
Tee KK, Kantor R, Sungkanuparph S, Takebe Y, Li P, Ditangco R, Phanuphak P, Sirisanthana T, Sim B, Ratanasuwan W, Kantipong P, Kamarulzaman A, TREAT Asia Studies to Evaluate Resistance-Monitoring (TASER-M) Database.
"Transmission Networks of HIV-1 Among Men Who Have Sex With Men in East and Southeast Asia." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 70, no. 1, 2015, pp. e28-30.
|
|
Kantor, Rami, DeLong, Allison, Balamane, Maya, Schreier, Leeann, Lloyd, Robert M, Injera, Wilfred, Kamle, Lydia, Mambo, Fidelis, Muyonga, Sarah, Katzenstein, David, Hogan, Joseph, Buziba, Nathan, Diero, Lameck.
"HIV diversity and drug resistance from plasma and non-plasma analytes in a large treatment programme in western Kenya." Journal of the International AIDS Society, vol. 17, no. 1, 2014.
|
|
Kantor, Rami, DeLong, Allison, Balamane, Maya, Schreier, Leeann, Lloyd, Robert M, Injera, Wilfred, Kamle, Lydia, Mambo, Fidelis, Muyonga, Sarah, Katzenstein, David, Hogan, Joseph, Buziba, Nathan, Diero, Lameck.
"HIV diversity and drug resistance from plasma and non-plasma analytes in a large treatment programme in western Kenya." Journal of the International AIDS Society, vol. 17, no. 1, 2014, pp. 19262.
|
|
Jiamsakul A, Sungkanuparph S, Law M, Kantor R, Praparattanapan J, Li PC, Phanuphak P, Merati T, Ratanasuwan W, Lee CK, Ditangco R, Mustafa M, Singtoroj T, Kiertiburanakul S, TREAT Asia Studies to Evaluate Resistance – Monitoring Study (TASER-M).
"HIV multi-drug resistance at first-line antiretroviral failure and subsequent virological response in Asia." Journal of the International AIDS Society, vol. 17, 2014, pp. 19053.
|
|
Kantor R, Bettendorf D, Bosch RJ, Mann M, Katzenstein D, Cu-Uvin S, D'Aquila R, Frenkel L, Fiscus S, Coombs R, ACTG A5077 Study Team.
"HIV-1 RNA levels and antiretroviral drug resistance in blood and non-blood compartments from HIV-1-infected men and women enrolled in AIDS clinical trials group study A5077." PLoS ONE, vol. 9, no. 4, 2014, pp. e93537.
|
|
Chan, Philip A., Reitsma, Marissa B., DeLong, Allison, Boucek, Bruce, Nunn, Amy, Salemi, Marco, Kantor, Rami.
"Phylogenetic and geospatial evaluation of HIV-1 subtype diversity at the largest HIV center in Rhode Island." Infection, Genetics and Evolution, vol. 28, 2014, pp. 358-366.
|
|
Alemnji G, Fonjungo P, Van Der Pol B, Peter T, Kantor R, Nkengasong J.
"The centrality of laboratory services in the HIV treatment and prevention cascade: The need for effective linkages and referrals in resource-limited settings." AIDS Patient Care and STDs, vol. 28, no. 5, 2014, pp. 268-73.
|
|
Phanuphak P, Sirivichayakul S, Jiamsakul A, Sungkanuparph S, Kumarasamy N, Lee MP, Sirisanthana T, Kantipong P, Lee C, Kamarulzaman A, Mustafa M, Ditangco R, Merati T, Ratanasuwan W, Singtoroj T, Kantor R.
"Transmitted drug resistance and antiretroviral treatment outcomes in non-subtype B HIV-1-infected patients in South East Asia." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 66, no. 1, 2014, pp. 74-9.
|
|
Sirivichayakul, S., Kantor, R., DeLong, A. K., Wongkunya, R., Mekprasan, S., Ruxrungtham, K., Sohn, A. H., Phanuphak, P.
"Transmitted HIV drug resistance at the Thai Red Cross Anonymous Clinic in Bangkok: results from three consecutive years of annual surveillance." Journal of Antimicrobial Chemotherapy, 2014.
|
|
Kantor R.
"Virulence profile: Rami Kantor." Virulence, vol. 5, no. 4, 2014, pp. 581-4.
|
|
Mann M, Diero L, Kemboi E, Mambo F, Rono M, Injera W, Delong A, Schreier L, Wools-Kaloustian K, Sidle J, Buziba N, Kantor R.
"Antiretroviral treatment interruptions induced by the Kenyan postelection crisis are associated with virological failure." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 64, no. 2, 2013, pp. 220-4.
|
|
Land S, Zhou J, Cunningham P, Sohn AH, Singtoroj T, Katzenstein D, Mann M, Sayer D, Kantor R.
"Capacity building and predictors of success for HIV-1 drug resistance testing in the Asia-Pacific region and Africa." Journal of the International AIDS Society, vol. 16, no. 1, 2013, pp. 18580.
|
|
Saravanan S, Madhavan V, Balakrishnan P, Smith DM, Solomon SS, Sivamalar S, Poongulali S, Kumarasamy N, Schooley RT, Solomon S, Kantor R.
"Darunavir is a good third-line antiretroviral agent for HIV type 1-infected patients failing second-line protease inhibitor-based regimens in South India." AIDS Research and Human Retroviruses, vol. 29, no. 3, 2013, pp. 630-2.
|
|
Morabito K, Kantor R, Tai W, Schreier L, Tripathi A.
"Detection of HIV-1 minority variants containing the K103N drug-resistance mutation using a simple method to amplify RNA targets (SMART)." The Journal of molecular diagnostics : JMD, vol. 15, no. 3, 2013, pp. 401-12.
|
|
Mann M, Lurie MN, Kimaiyo S, Kantor R.
"Effects of political conflict-induced treatment interruptions on HIV drug resistance." AIDS reviews, vol. 15, no. 1, 2013, pp. 15-24.
|
|
Coetzer M, Westley B, Delong A, Tray C, Sophearin D, Nerrienet E, Schreier L, Kantor R.
"Extensive drug resistance in HIV-infected Cambodian children who are undetected as failing first-line antiretroviral therapy by WHO 2010 guidelines." AIDS Research and Human Retroviruses, vol. 29, no. 7, 2013, pp. 985-92.
|
|
Liu, Tao, Hogan, Joseph W., Wang, Lisa, Zhang, Shangxuan, Kantor, Rami.
"Optimal Allocation of Gold Standard Testing under Constrained Availability: Application to Assessment of HIV Treatment Failure." Journal of the American Statistical Association, vol. 108, no. 504, 2013, pp. 1173-1188.
|
|
Venkatesh KK, DeLong AK, Kantor R, Chapman S, Ingersoll J, Kurpewski J, De Pasquale MP, D'Aquila R, Caliendo AM, Cu-Uvin S.
"Persistent genital tract HIV-1 RNA shedding after change in treatment regimens in antiretroviral-experienced women with detectable plasma viral load." Journal of Women's Health, vol. 22, no. 4, 2013, pp. 330-8.
|
|
Kantor R.
"Research components of the Brown Kenya Program: a personal and professional perspective." Rhode Island medical journal (2013), vol. 96, no. 10, 2013, pp. 16-9.
|
|
Sungkanuparph S, Jiamsakul A, Kiertiburanakul S, Sirivichayakul S, Praparattanapan J, Kantor R, TREAT Asia Studies to Evaluate Resistance.
"Rilpivirine resistance-associated mutations among antiretroviral-naive patients infected with HIV-1 in Asia." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 62, no. 3, 2013, pp. e98-100.
|
|
Chan PA, Kazi S, Rana A, Blazar I, Dejong CC, Mayer KH, Huard TK, Carleton K, Gillani F, Alexander N, Parillo Z, Flanigan TP, Kantor R.
"Short communication: new HIV infections at Southern New England academic institutions: implications for prevention." AIDS Research and Human Retroviruses, vol. 29, no. 1, 2013, pp. 25-9.
|
|
Jiamsakul A, Kantor R, Li PC, Sirivichayakul S, Sirisanthana T, Kantipong P, Lee CK, Kamarulzaman A, Ratanasuwan W, Ditangco R, Singtoroj T, Sungkanuparph S, TREAT Asia Studies to Evaluate Resistance – Monitoring Study (TASER-M).
"Comparison of predicted susceptibility between genotype and virtual phenotype HIV drug resistance interpretation systems among treatment-naive HIV-infected patients in Asia: TASER-M cohort analysis." BMC research notes, vol. 5, 2012, pp. 582.
|
|
Huang, Austin, Hogan, Joseph W, Istrail, Sorin, DeLong, Allison, Katzenstein, David A, Kantor, Rami.
"Global analysis of sequence diversity within HIV-1 subtypes across geographic regions." Future Virology, vol. 7, no. 5, 2012, pp. 505-517.
|
|
Alexander NE, Chan PA, Rogo TO, Parillo Z, Browning CA, Isabell BS, Calcione C, Chowdhury S, Simon P, Kantor R.
"Interrupting transmission of HIV and other sexually transmitted infections in Rhode Island." Medicine and health, Rhode Island, vol. 95, no. 8, 2012, pp. 241-4.
|
|
Chan PA, Huang A, Kantor R.
"Low prevalence of transmitted K65R and other tenofovir resistance mutations across different HIV-1 subtypes: implications for pre-exposure prophylaxis." Journal of the International AIDS Society, vol. 15, no. 2, 2012, pp. 17701.
|
|
Westley BP, DeLong AK, Tray CS, Sophearin D, Dufort EM, Nerrienet E, Schreier L, Harwell JI, Kantor R.
"Prediction of treatment failure using 2010 World Health Organization Guidelines is associated with high misclassification rates and drug resistance among HIV-infected Cambodian children." Clinical Infectious Diseases, vol. 55, no. 3, 2012, pp. 432-40.
|
|
Saravanan S, Madhavan V, Solomon SS, Kantor R, Katzenstein D, Sivamalar S, Kumarasamy N, Smith DM, Mayer KH, Solomon S, Balakrishnan P.
"Reverse transcriptase substitution at codons 208 and 228 among treatment-experienced HIV-1 subtype-C-infected Indian patients is strongly associated with thymidine analogue mutations." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 59, no. 2, 2012, pp. e26-7.
|
|
Delong AK, Wu M, Bennett D, Parkin N, Wu Z, Hogan JW, Kantor R.
"Sequence quality analysis tool for HIV type 1 protease and reverse transcriptase." AIDS Research and Human Retroviruses, vol. 28, no. 8, 2012, pp. 894-901.
|
|
Saravanan S, Madhavan V, Kantor R, Sivamalar S, Gomathi S, Solomon SS, Kumarasamy N, Smith DM, Schooley RT, Solomon S, Balakrishnan P.
"Unusual insertion and deletion at codon 67 and 69 of HIV type 1 subtype C reverse transcriptase among first-line highly active antiretroviral treatment-failing South Indian patients: association with other resistance mutations." AIDS Research and Human Retroviruses, vol. 28, no. 12, 2012, pp. 1763-5.
|
|
Saravanan S, Vidya M, Balakrishnan P, Kantor R, Solomon SS, Katzenstein D, Kumarasamy N, Yeptomi T, Sivamalar S, Rifkin S, Mayer KH, Solomon S.
"Viremia and HIV-1 drug resistance mutations among patients receiving second-line highly active antiretroviral therapy in Chennai, Southern India." Clinical Infectious Diseases, vol. 54, no. 7, 2012, pp. 995-1000.
|
|
El-Khatib Z, Delong AK, Katzenstein D, Ekstrom AM, Ledwaba J, Mohapi L, Laher F, Petzold M, Morris L, Kantor R.
"Drug resistance patterns and virus re-suppression among HIV-1 subtype C infected patients receiving non-nucleoside reverse transcriptase inhibitors in South Africa." Journal of AIDS & clinical research, vol. 2, no. 117, 2011.
|
|
Huang, A., Kantor, R., DeLong, A., Schreier, L., Istrail, S.
"QColors: An algorithm for conservative viral quasispecies reconstruction from short and non-contiguous next generation sequencing reads." 2011 IEEE International Conference on Bioinformatics and Biomedicine Workshops (BIBMW), 2011.
|
|
Huang A, Kantor R, DeLong A, Schreier L, Istrail S.
"QColors: an algorithm for conservative viral quasispecies reconstruction from short and non-contiguous next generation sequencing reads." In silico biology, vol. 11, no. 5-6, 2011, pp. 193-201.
|
|
Chan PA, Tashima K, Cartwright CP, Gillani FS, Mintz O, Zeller K, Kantor R.
"Short communication: Transmitted drug resistance and molecular epidemiology in antiretroviral naive HIV type 1-infected patients in Rhode Island." AIDS Research and Human Retroviruses, vol. 27, no. 3, 2011, pp. 275-81.
|
|
Saravanan S, Madhavan V, Murugavel KG, Balakrishnan P, Solomon SS, Umapathy S, Kantor R, Kumarasamy N, Yepthomi T, Smith DM, Mayer KH, Solomon S.
"The association between HIV-1 subtype C antiretroviral resistance and HLA prevalence in southern India." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 57, no. 1, 2011, pp. e17-9.
|
|
Bennett DE, Camacho RJ, Otelea D, Kuritzkes DR, Fleury H, Kiuchi M, Heneine W, Kantor R, Jordan MR, Schapiro JM, Vandamme AM, Sandstrom P, Boucher CA, van de Vijver D, Rhee SY, Liu TF, Pillay D, Shafer RW.
"Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update." PLoS ONE, vol. 4, no. 3, 2009, pp. e4724.
|
|
Kassaye S, Johnston E, McColgan B, Kantor R, Zijenah L, Katzenstein D.
"Envelope coreceptor tropism, drug resistance, and viral evolution among subtype C HIV-1-infected individuals receiving nonsuppressive antiretroviral therapy." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 50, no. 1, 2009, pp. 9-18.
|
|
Saravanan S, Vidya M, Balakrishnan P, Kumarasamy N, Solomon SS, Solomon S, Kantor R, Katzenstein D, Ramratnam B, Mayer KH.
"Evaluation of two human immunodeficiency virus-1 genotyping systems: ViroSeq 2.0 and an in-house method." Journal of virological methods, vol. 159, no. 2, 2009, pp. 211-6.
|
|
Vidya M, Saravanan S, Uma S, Kumarasamy N, Sunil SS, Kantor R, Katzenstein D, Ramratnam B, Mayer KH, Suniti S, Balakrishnan P.
"Genotypic HIV type-1 drug resistance among patients with immunological failure to first-line antiretroviral therapy in south India." Antiviral therapy, vol. 14, no. 7, 2009, pp. 1005-9.
|
|
Kumarasamy N, Madhavan V, Venkatesh KK, Saravanan S, Kantor R, Balakrishnan P, Devaleenal B, Poongulali S, Yepthomi T, Solomon S, Mayer KH, Benson C, Schooley R.
"High frequency of clinically significant mutations after first-line generic highly active antiretroviral therapy failure: implications for second-line options in resource-limited settings." Clinical Infectious Diseases, vol. 49, no. 2, 2009, pp. 306-9.
|
|
Kantor, Rami, Diero, Lameck, DeLong, Allison, Kamle, Lydia, Muyonga, Sarah, Mambo, Fidelis, Walumbe, Eunice, Emonyi, Wilfred, Chan, Philip, Carter, E. Jane, Hogan, Joseph, Buziba, Nathan.
"Misclassification of First‐Line Antiretroviral Treatment Failure Based on Immunological Monitoring of HIV Infection in Resource‐Limited Settings." Clinical Infectious Diseases, vol. 49, no. 3, 2009, pp. 454-62.
|
|
Chan PA, Kantor R.
"Transmitted drug resistance in nonsubtype B HIV-1 infection." HIV Therapy, vol. 3, no. 5, 2009, pp. 447-465.
|
|
Land S, Cunningham P, Zhou J, Frost K, Katzenstein D, Kantor R, Chen YM, Oka S, DeLong A, Sayer D, Smith J, Dax EM, Law M, TAQAS Laboratory Network.
"TREAT Asia Quality Assessment Scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratories." Journal of virological methods, vol. 159, no. 2, 2009, pp. 185-93.
|
|
Deforche K, Camacho RJ, Grossman Z, Soares MA, Van Laethem K, Katzenstein DA, Harrigan PR, Kantor R, Shafer R, Vandamme AM, non-B Workgroup.
"Bayesian network analyses of resistance pathways against efavirenz and nevirapine." AIDS, vol. 22, no. 16, 2008, pp. 2107-15.
|
|
Pillay V, Pillay C, Kantor R, Venter F, Levin L, Morris L.
"HIV type 1 subtype C drug resistance among pediatric and adult South African patients failing antiretroviral therapy." AIDS Research and Human Retroviruses, vol. 24, no. 11, 2008, pp. 1449-54.
|
|
Chan PA, Wakeman SE, Flanigan T, Cu-Uvin S, Kojic E, Kantor R.
"HIV-2 diagnosis and quantification in high-risk patients." AIDS research and therapy, vol. 5, 2008, pp. 18.
|
|
Deforche K, Camacho R, Grossman Z, Silander T, Soares MA, Moreau Y, Shafer RW, Van Laethem K, Carvalho AP, Wynhoven B, Cane P, Snoeck J, Clarke J, Sirivichayakul S, Ariyoshi K, Holguin A, Rudich H, Rodrigues R, Bouzas MB, Cahn P, Brigido LF, Soriano V, Sugiura W, Phanuphak P, Morris L, Weber J, Pillay D, Tanuri A, Harrigan PR, Shapiro JM, Katzenstein DA, Kantor R, Vandamme AM.
"Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors." Infection, Genetics and Evolution, vol. 7, no. 3, 2007, pp. 382-90.
|
|
Kassaye S, Lee E, Kantor R, Johnston E, Winters M, Zijenah L, Mateta P, Katzenstein D.
"Drug resistance in plasma and breast milk after single-dose nevirapine in subtype C HIV type 1: population and clonal sequence analysis." AIDS Research and Human Retroviruses, vol. 23, no. 8, 2007, pp. 1055-61.
|
|
Rami Kantor, Jonathan Gershoni.
"HIV/AIDS and the Genetic Revolution - Custom Tailoring Antiretroviral Regimens in the Management of HIV." vol. 7, 2007, pp. 478-491.
|
|
Deforche K, Silander T, Camacho R, Grossman Z, Soares MA, Van Laethem K, Kantor R, Moreau Y, Vandamme AM, non-B Workgroup.
"Analysis of HIV-1 pol sequences using Bayesian Networks: implications for drug resistance." Bioinformatics, vol. 22, no. 24, 2006, pp. 2975-9.
|
|
Snoeck J, Kantor R, Shafer RW, Van Laethem K, Deforche K, Carvalho AP, Wynhoven B, Soares MA, Cane P, Clarke J, Pillay C, Sirivichayakul S, Ariyoshi K, Holguin A, Rudich H, Rodrigues R, Bouzas MB, Brun-Vézinet F, Reid C, Cahn P, Brigido LF, Grossman Z, Soriano V, Sugiura W, Phanuphak P, Morris L, Weber J, Pillay D, Tanuri A, Harrigan RP, Camacho R, Schapiro JM, Katzenstein D, Vandamme AM.
"Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent." Antimicrobial Agents and Chemotherapy, vol. 50, no. 2, 2006, pp. 694-701.
|
|
Rhee SY, Kantor R, Katzenstein DA, Camacho R, Morris L, Sirivichayakul S, Jorgensen L, Brigido LF, Schapiro JM, Shafer RW, International Non Subtype B HIV-1 Working Group.
"HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes." AIDS, vol. 20, no. 5, 2006, pp. 643-51.
|
|
Kantor R.
"Impact of HIV-1 pol diversity on drug resistance and its clinical implications." Current opinion in infectious diseases, vol. 19, no. 6, 2006, pp. 594-606.
|
|
Lee EJ, Kantor R, Zijenah L, Sheldon W, Emel L, Mateta P, Johnston E, Wells J, Shetty AK, Coovadia H, Maldonado Y, Jones SA, Mofenson LM, Contag CH, Bassett M, Katzenstein DA, HIVNET 023 Study Team.
"Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine." The Journal of Infectious Diseases, vol. 192, no. 7, 2005, pp. 1260-4.
|
|
Balakrishnan P, Kumarasamy N, Kantor R, Solomon S, Vidya S, Mayer KH, Newstein M, Thyagarajan SP, Katzenstein D, Ramratnam B.
"HIV type 1 genotypic variation in an antiretroviral treatment-naive population in southern India." AIDS Research and Human Retroviruses, vol. 21, no. 4, 2005, pp. 301-5.
|
|
Kantor R, Katzenstein DA, Efron B, Carvalho AP, Wynhoven B, Cane P, Clarke J, Sirivichayakul S, Soares MA, Snoeck J, Pillay C, Rudich H, Rodrigues R, Holguin A, Ariyoshi K, Bouzas MB, Cahn P, Sugiura W, Soriano V, Brigido LF, Grossman Z, Morris L, Vandamme AM, Tanuri A, Phanuphak P, Weber JN, Pillay D, Harrigan PR, Camacho R, Schapiro JM, Shafer RW.
"Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration." PLOS Medicine, vol. 2, no. 4, 2005, pp. e112.
|
|
Kantor R, Shafer RW, Katzenstein D, HIV-1 Non-subtype B Workgroup*.
"The HIV-1 Non-subtype B Workgroup: An International Collaboration for the Collection and Analysis of HIV-1 Non-subtype B Data." Journal of the International AIDS Society, vol. 7, no. 1, 2005, pp. 71.
|
|
Kantor R, Shafer RW, Katzenstein D, HIV-1 Non-subtype B Workgroup.
"The HIV-1 Non-subtype B Workgroup: an international collaboration for the collection and analysis of HIV-1 non-subtype B data." MedGenMed : Medscape general medicine, vol. 7, no. 1, 2005, pp. 71.
|
|
Kantor R, Katzenstein D.
"Drug resistance in non-subtype B HIV-1." Journal of Clinical Virology, vol. 29, no. 3, 2004, pp. 152-9.
|
|
Kantor R, Shafer RW, Follansbee S, Taylor J, Shilane D, Hurley L, Nguyen DP, Katzenstein D, Fessel WJ.
"Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy." AIDS, vol. 18, no. 11, 2004, pp. 1503-11.
|
|
Akinsete O, Hirigoyen D, Cartwright C, Schut R, Kantor R, Henry K.
"K103N mutation in antiretroviral therapy-naive African patients infected with HIV type 1." Clinical Infectious Diseases, vol. 39, no. 4, 2004, pp. 575-8.
|
|
Kantor R, Bakhanashvili M, Achiron A.
"A mutated CCR5 gene may have favorable prognostic implications in MS." Neurology, vol. 61, no. 2, 2003, pp. 238-40.
|
|
Peleg M, Kantor R.
"Approaches for guideline versioning using GLIF." AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium, 2003, pp. 509-13.
|
|
Gonzales MJ, Wu TD, Taylor J, Belitskaya I, Kantor R, Israelski D, Chou S, Zolopa AR, Fessel WJ, Shafer RW.
"Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors." AIDS, vol. 17, no. 6, 2003, pp. 791-9.
|
|
Johnston ER, Zijenah LS, Mutetwa S, Kantor R, Kittinunvorakoon C, Katzenstein DA.
"High frequency of syncytium-inducing and CXCR4-tropic viruses among human immunodeficiency virus type 1 subtype C-infected patients receiving antiretroviral treatment." Journal of Virology, vol. 77, no. 13, 2003, pp. 7682-8.
|
|
Rhee SY, Gonzales MJ, Kantor R, Betts BJ, Ravela J, Shafer RW.
"Human immunodeficiency virus reverse transcriptase and protease sequence database." Nucleic acids research, vol. 31, no. 1, 2003, pp. 298-303.
|
|
Wu TD, Schiffer CA, Gonzales MJ, Taylor J, Kantor R, Chou S, Israelski D, Zolopa AR, Fessel WJ, Shafer RW.
"Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments." Journal of Virology, vol. 77, no. 8, 2003, pp. 4836-47.
|
|
Kantor R, Katzenstein D.
"Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution." AIDS reviews, vol. 5, no. 1, 2003, pp. 25-35.
|
|
Kantor R, Fessel WJ, Zolopa AR, Israelski D, Shulman N, Montoya JG, Harbour M, Schapiro JM, Shafer RW.
"Evolution of primary protease inhibitor resistance mutations during protease inhibitor salvage therapy." Antimicrobial Agents and Chemotherapy, vol. 46, no. 4, 2002, pp. 1086-92.
|
|
Kantor R, Zijenah LS, Shafer RW, Mutetwa S, Johnston E, Lloyd R, von Lieven A, Israelski D, Katzenstein DA.
"HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy." AIDS Research and Human Retroviruses, vol. 18, no. 18, 2002, pp. 1407-13.
|
|
Kantor R, Pauzner R, Golubev N, Shinfeld A, Farfel Z, Smolinsky AK.
"Ascending aortic pseudoaneurysm following coronary bypass in a hemodialysis patient with fever of unknown origin." The Journal of cardiovascular surgery, vol. 42, no. 5, 2001, pp. 633-4.
|
|
Mayan H, Kantor R, Rimon U, Golubev N, Heyman Z, Goshen E, Shalmon B, Weiss P.
"Fatal liver infarction after transjugular intrahepatic portosystemic shunt procedure." Liver, vol. 21, no. 5, 2001, pp. 361-4.
|
|
Kantor R, Machekano R, Gonzales MJ, Dupnik K, Schapiro JM, Shafer RW.
"Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database: an expanded data model integrating natural language text and sequence analysis programs." Nucleic acids research, vol. 29, no. 1, 2001, pp. 296-9.
|
|
Mayan H, Kantor R, Farfel Z.
"Trans-tubular potassium gradient in patients with drug-induced hyperkalemia." Nephron, vol. 89, no. 1, 2001, pp. 56-61.
|
|
Kantor R, Mayan H, Yaron D.
"[Acquired hemophilia]." Harefuah, vol. 138, no. 10, 2000, pp. 860-4.
|
|
Kantor R, Mayan H, Puritz L, Varon D, Farfel Z.
"Acquired hemophilia masked by warfarin therapy." The American Journal of the Medical Sciences, vol. 319, no. 3, 2000, pp. 197-201.
|
|
Kantor R, Mayan H, Shalmon B, Reichert N, Farfel Z.
"Kaposi's sarcoma after lung transplantation in a Sephardic Jewish woman." Dermatology (Basel, Switzerland), vol. 200, no. 1, 2000, pp. 49-50.
|
|
Shafer RW, Kantor R, Gonzales MJ.
"The Genetic Basis of HIV-1 Resistance to Reverse Transcriptase and Protease Inhibitors." AIDS reviews, vol. 2, no. 4, 2000, pp. 211-228.
|
|
Kantor R, Gershoni JM.
"[CCR5--the HIV co-receptor--now in Israel]." Harefuah, vol. 137, no. 9, 1999, pp. 405-9.
|
|
Kantor R, Pauzner R, Pali E, Farfel Z.
"[High alkaline phosphatase in subacute thyroiditis]." Harefuah, vol. 136, no. 8, 1999, pp. 599-602, 659.
|
|
Kantor R, Gershoni JM.
"Distribution of the CCR5 gene 32-base pair deletion in Israeli ethnic groups." Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, vol. 20, no. 1, 1999, pp. 81-4.
|
|
Kantor R, Barzilai A, Varon D, Martinowitz U, Gershoni JM.
"Prevalence of a CCR5 gene 32-bp deletion in an Israeli cohort of HIV-1-infected and uninfected hemophilia patients." Journal of human virology, vol. 1, no. 4, 1998, pp. 299-301.
|
|
Kantor R, Salai M, Ganel A.
"Orthopaedic long term aspects of bladder exstrophy." Clinical Orthopaedics and Related Research®, no. 335, 1997, pp. 240-5.
|
